Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules.

Journal of the American Chemical Societyยท2025
Same author

Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA).

Journal of the American Chemical Societyยท2025
Same author

Inhibitors supercharge kinase turnover through native proteolytic circuits.

Natureยท2025
Same author

Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy.

bioRxiv : the preprint server for biologyยท2025
Same author

Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Researchยท2025
Same author

Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes.

Journal of the American Chemical Societyยท2025

Related Experiment Video

Updated: Jul 6, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

High-throughput kinase profiling as a platform for drug discovery.

David M Goldstein1, Nathanael S Gray, Patrick P Zarrinkar

  • 1Roche Palo Alto, 3431 Hillview Avenue, R6-201, Palo Alto, California 94304, USA.

Nature Reviews. Drug Discovery
|April 12, 2008
PubMed
Summary

High-throughput kinase profiling accelerates inhibitor discovery by testing compounds against many targets at once. This parallel approach identifies potent and selective kinase inhibitors more efficiently than traditional methods.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Cost-Efficient Transcriptomic-Based Drug Screening
06:40

Cost-Efficient Transcriptomic-Based Drug Screening

Published on: February 23, 2024

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Kinases are crucial drug targets, but efficient inhibitor discovery remains a challenge.
  • Traditional inhibitor discovery methods are often linear and time-consuming.

Purpose of the Study:

  • To introduce high-throughput kinase profiling as a novel strategy for inhibitor discovery.
  • To enable a parallel approach for interrogating compounds against numerous kinase targets simultaneously.

Main Methods:

  • Utilizing high-throughput screening to test compounds against hundreds of kinase targets in a single assay.
  • Simultaneously determining compound potency and selectivity across multiple targets.

Main Results:

  • High-throughput profiling allows for parallel interrogation of compounds against numerous kinases.
  • Simultaneous assessment of potency and selectivity guides target selection based on lead compound quality.

Conclusions:

  • High-throughput kinase profiling offers an efficient alternative to traditional inhibitor discovery.
  • This method enhances drug discovery by prioritizing targets based on available high-quality lead compounds.